The Griffithsin Dimer Is Required for High-Potency Inhibition of HIV-1: Evidence for Manipulation of the Structure of gp120 as Part of the Griffithsin Dimer Mechanism

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2013-06-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1128/AAC.00332-13PMID 23752505PMCID PMC3719714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV‐1 envelope trimer has similar binding characteristics for carbohydrate‐binding agents as monomeric gp120

  2013cited by this paper
• Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread

  2013cited by this paper
• Role of the Carbohydrate-Binding Sites of Griffithsin in the Prevention of DC-SIGN-Mediated Capture and Transmission of HIV-1

  2013cited by this paper
• Title Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp 120 and gp

  2012cited by this paper
• HIV microbicides: where are we now?

  2012cited by this paper
• Association of Enhanced HIV-1 Neutralization by a Single Y681H Substitution in gp41 with Increased gp120-CD4 Interaction and Macrophage Infectivity

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012cited by this paper
• Combinations of Griffithsin with Other Carbohydrate-Binding Agents Demonstrate Superior Activity Against HIV Type 1, HIV Type 2, and Selected Carbohydrate-Binding Agent-Resistant HIV Type 1 Strains

  2012cited by this paper
• Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation

  2012cited by this paper
• Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer

  2012cited by this paper
• Occluding the Mannose Moieties on Human Immunodeficiency Virus Type 1 gp120 with Griffithsin Improves the Antibody Responses to Both Proteins in Mice

  2012cited by this paper
• The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.

  2012cited by this paper
• Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo

  2012cited by this paper
• A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams. 1991.

  2011cited by this paper
• Designed oligomers of cyanovirin-N show enhanced HIV neutralization

  2011cited by this paper
• Griffithsin Has Antiviral Activity against Hepatitis C Virus

  2011cited by this paper
• Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures

  2011cited by this paper
• Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand binding

  2011cited by this paper
• Polyreactive antibodies in adaptive immune responses to viruses

  2011cited by this paper
• Degradation of naturally occurring and engineered antimicrobial peptides by proteases.

  2011cited by this paper
• Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity

  2011cited by this paper
• Binding of the Mannose-Specific Lectin, Griffithsin, to HIV-1 gp120 Exposes the CD4-Binding Site

  2011cited by this paper
• Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01

  2011cited by this paper
• Dimeric 2G12 as a potent protection against HIV-1 (53.26)

  2011cited by this paper
• Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin.

  2011cited by this paper
• A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

  2011cited by this paper
• Investigation of Griffithsin's Interactions with Human Cells Confirms Its Outstanding Safety and Efficacy Profile as a Microbicide Candidate

  2011cited by this paper
• Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently under Development as Microbicides

  2011cited by this paper
• Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope

  2010cited by this paper
• Monomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV Activity

  2010cited by this paper
• Dimeric 2G12 as a Potent Protection against HIV-1

  2010cited by this paper
• Anti-HIV Activity of Defective Cyanovirin-N Mutants Is Restored by Dimerization*

  2010cited by this paper
• Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

  2010cited by this paper
• Methods for the Design and Analysis of Sedimentation Velocity and Sedimentation Equilibrium Experiments with Proteins

  2010cited by this paper
• Single-particle cryoelectron microscopy analysis reveals the HIV-1 spike as a tripod structure

  2010cited by this paper
• Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens

  2010cited by this paper
• Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.

  2010cited by this paper
• Few and Far Between: How HIV May Be Evading Antibody Avidity

  2010cited by this paper
• A two-dimensional spectrum analysis for sedimentation velocity experiments of mixtures with heterogeneity in molecular weight and shape

  2010cited by this paper
• Molecular Architectures of Trimeric SIV and HIV-1 Envelope Glycoproteins on Intact Viruses: Strain-Dependent Variation in Quaternary Structure

  2010cited by this paper
• Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

  2009cited by this paper
• Mechanism by which the lectin actinohivin blocks HIV infection of target cells

  2009cited by this paper
• Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

  2009cited by this paper
• Second-generation HIV microbicides: Continued development of griffithsin

  2009cited by this paper
• Design and Expression of a Dimeric Form of Human Immunodeficiency Virus Type 1 Antibody 2G12 with Increased Neutralization Potency

  2008cited by this paper
• Parallel computational techniques for the analysis of sedimentation velocity experiments in UltraScan

  2008cited by this paper
• Monte Carlo analysis of sedimentation experiments

  2008cited by this paper
• Molecular architecture of native HIV-1 gp120 trimers

  2008cited by this paper
• Functional Links between the Fusion Peptide-proximal Polar Segment and Membrane-proximal Region of Human Immunodeficiency Virus gp41 in Distinct Phases of Membrane Fusion*

  2007cited by this paper
• Crystallographic studies of the complexes of antiviral protein griffithsin with glucose and N-acetylglucosamine

  2007cited by this paper
• Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin† ‡

  2007cited by this paper
• Parsimonious regularization using genetic algorithms applied to the analysis of analytical ultracentrifugation experiments

  2007cited by this paper
• Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.

  2007cited by this paper
• Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy

  2007cited by this paper
• Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti‐HIV microbicide

  2007cited by this paper
• High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization.

  2007cited by this paper
• Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa

  2006cited by this paper
• Genetic algorithm optimization for obtaining accurate molecular weight distributions from sedimentation velocity experiments

  2006cited by this paper
• Computing Large Sparse Multivariate Optimization Problems with an Application in Biophysics

  2006cited by this paper
• Distribution and three-dimensional structure of AIDS virus envelope spikes

  2006cited by this paper
• Domain-Swapped Structure of the Potent Antiviral Protein Griffithsin and Its Mode of Carbohydrate Binding

  2006cited by this paper
• Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

  2005cited by this paper
• UltraScan - A Comprehensive Data Analysis Software Package for Analytical Ultracentrifugation Experiments

  2005cited by this paper
• Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp.*

  2005cited by this paper
• The highly specific carbohydrate-binding protein cyanovirin-N: structure, anti-HIV/Ebola activity and possibilities for therapy.

  2005cited by this paper
• Sedimentation velocity analysis of highly heterogeneous systems.

  2004cited by this paper
• Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission

  2004cited by this paper
• N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies

  2004cited by this paper
• Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.

  2004cited by this paper
• UCSF Chimera—A visualization system for exploratory research and analysis

  2004cited by this paper
• Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity.

  2004cited by this paper
• Antibody neutralization and escape by HIV-1

  2003cited by this paper
• Characterization of Human Class-Switched Polymeric (Immunoglobulin M [IgM] and IgA) Anti-Human Immunodeficiency Virus Type 1 Antibodies 2F5 and 2G12

  2003cited by this paper
• Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development

  2003cited by this paper
• Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition

  2003cited by this paper
• The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120

  2002cited by this paper
• Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy

  2002cited by this paper
• The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120

  2002cited by this paper
• Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells.

  2000cited by this paper
• A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure

  2000cited by this paper
• Solution structure of cyanovirin-N, a potent HIV-inactivating protein

  1998cited by this paper
• Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

  1997cited by this paper
• Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

  1996cited by this paper
• N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120

  1996cited by this paper
• Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein

  1996cited by this paper
• N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure

  1996cited by this paper
• Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.

  1995cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.

  1994cited by this paper
• Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1

  1994cited by this paper
• Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.

  1992cited by this paper
• Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events

  1992cited by this paper
• Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.

  1991cited by this paper
• A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.

  1991cited by this paper
• A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams

  1991cited by this paper
• Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.

  1990cited by this paper
• Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

  1990cited by this paper

• Leveraging Antiviral Lectins for Developing Glycan-Based Vaccines by Employing Standard and AI-Driven Approaches

  2025cites this paper
• Bridging Viral Glycobiology and Lectin Biotechnology for Antiviral and Diagnostic Strategies

  2025cites this paper
• Expression and antiviral application of exogenous lectin (griffithsin) in sweetpotatoes

  2024cites this paper
• HIV-1 interaction with an O-glycan-specific bacterial lectin enhances virus infectivity and resistance to neutralizing antibodies

  2024cites this paper
• Sustained Delivery of the Antiviral Protein Griffithsin and Its Adhesion to a Biological Surface by a Silk Fibroin Scaffold

  2023cites this paper
• HIV-1 interaction with an O-glycan-specific bacterial lectin enhances virus infectivity and resistance to neutralization by antibodies

  2023cites this paper
• The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins

  2023influential citation
• The Antiviral Potential of Algal Lectins

  2023cites this paper
• Lectins and lectibodies: potential promising antiviral agents

  2022cites this paper
• Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses

  2022cites this paper
• Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses

  2021cites this paper
• Algal and Cyanobacterial Lectins and Their Antimicrobial Properties

  2021cites this paper
• Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin

  2020cites this paper
• Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge

  2020cites this paper
• Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2

  2020cites this paper
• Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo

  2020cites this paper
• Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

  2020cites this paper
• Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application

  2019influential citation
• Marine Algae Metabolites as Promising Therapeutics for the Prevention and Treatment of HIV/AIDS

  2019cites this paper
• Mannose-Specific Lectins from Marine Algae: Diverse Structural Scaffolds Associated to Common Virucidal and Anti-Cancer Properties

  2019cites this paper
• Novel Antiretroviral Structures from Marine Organisms

  2019cites this paper
• Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126

  2019cites this paper
• HIV-1 Envelope Glycan Composition as a Key Determinant of Efficient Virus Transmission via DC-SIGN and Resistance to Inhibitory Lectins

  2019cites this paper
• Gene-silencing suppressors for high-level production of the HIV-1 entry inhibitor griffithsin in Nicotiana benthamiana

  2018cites this paper
• Heterologous production of recombinant anti-HIV microbicide griffithsin in transgenic lettuce and tobacco lines

  2018cites this paper
• Pharmaceutical Approaches to HIV Treatment and Prevention

  2018cites this paper
• Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections.

  2017cites this paper
• Lectins from red algae and their biomedical potential

  2017influential citation
• Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection

  2016cites this paper
• Rice endosperm is cost‐effective for the production of recombinant griffithsin with potent activity against HIV

  2016cites this paper
• Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential

  2016influential citation
• Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus

  2015cites this paper
• [Structure and Function of a Novel Class of High Mannose-binding Proteins with Anti-viral or Anti-tumor Activity].

  2015cites this paper
• Bulk production of the antiviral lectin griffithsin

  2015cites this paper
• Entry Inhibition of Influenza Viruses with High Mannose Binding Lectin ESA-2 from the Red Alga Eucheuma serra through the Recognition of Viral Hemagglutinin

  2015cites this paper
• Novel Prospective Treatment Options

  2015cites this paper
• High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120

  2015cites this paper
• High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120

  2015influential citation
• Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus

  2015cites this paper
• Evaluation of the safety and pharmacokinetic profile of the broad spectrum antiviral lectin Griffithsin.

  2014cites this paper
• HIV-1 and Its Resistance to Peptidic Carbohydrate-Binding Agents (CBAs): An Overview

  2014cites this paper